chlorpromazine has been researched along with procainamide in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (46.00) | 18.7374 |
1990's | 2 (4.00) | 18.2507 |
2000's | 12 (24.00) | 29.6817 |
2010's | 13 (26.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Bednarczyk, D; Ekins, S; Wikel, JH; Wright, SH | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Sen, S; Sinha, N | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dubois, EL | 1 |
Hall, GM; Lister, D; Lucke, JN | 1 |
Schwarz, JA | 1 |
Maas, D; Schubothe, H | 1 |
Burlingame, RW; Rubin, RL | 1 |
Cush, JJ; Goldings, EA | 1 |
Asboe-Hansen, G; Blumenkrantz, N | 1 |
Harpey, JP | 1 |
Joshi, BK; Namaji, KJ; Sadre, NL; Tiwari, NM | 1 |
Catania, PN; King, JC | 1 |
Yoshikawa, K | 1 |
Chazotte, B; Chignell, D; Vanderkooi, G | 1 |
Ciofalo, FR | 1 |
Angrist, BM | 1 |
Harmon, CE; Portanova, JP | 1 |
Weinstein, A | 1 |
Faulkner, GD; Kilpatrick, BF; Main, AR; Rush, RS | 1 |
Hess, EV | 1 |
Jiang, X; Khursigara, G; Rubin, RL | 1 |
MATTURRO, F | 1 |
STANISZEWSKI, K | 1 |
MAEKAWA, M; NOHARA, Y | 1 |
KOERNER, M | 1 |
BERTRAND, A; BONNET, H; GIRAUD, G; LATOUR, H; LEVY, A; PUECH, P | 1 |
Baeza, I; Campos, B; Farfán, N; Flores-Romo, L; Hernández-Pando, R; Ibáñez, M; Lara, M; Leyva, E; Orozco, H; Wong, C | 1 |
Baeza, I; Bustos, I; Hernández-Pando, R; Ibáñez, M; Reséndiz, A; Tescucano, A; Wong, C; Wong-Baeza, C | 1 |
7 review(s) available for chlorpromazine and procainamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Serologic abnormalities in spontaneous and drug-induced systemic lupus erythematosus.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Anti-Idiotypic; Antibodies, Antinuclear; Anticonvulsants; Antihypertensive Agents; Antitubercular Agents; Azathioprine; California; Chlorpromazine; Complement System Proteins; Contraceptives, Oral, Synthetic; DNA; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Neutrophils; Phenothiazines; Pregnancy; Procainamide | 1975 |
Treatment of porcine malignant hyperthermia. A review based on experimental studies.
Topics: Animals; Blood Glucose; Body Temperature; Carbon Dioxide; Catecholamines; Chlorpromazine; Dantrolene; Electrocardiography; Halothane; Humans; Hydrogen-Ion Concentration; Magnesium; Malignant Hyperthermia; Muscle Rigidity; Phentolamine; Potassium; Procainamide; Procaine; Succinylcholine; Swine; Triiodothyronine | 1975 |
Drug-induced lupus: clinical spectrum and pathogenesis.
Topics: Acetylation; Adult; Aged; Antibodies, Antinuclear; Antibody Specificity; Autoimmune Diseases; Black People; Brain; Chlorpromazine; Female; Heart; Humans; Hydralazine; Isoniazid; Kidney; Liver; Lung; Lupus Erythematosus, Systemic; Male; Methyldopa; Muscles; Phenotype; Procainamide | 1985 |
Lupus-like syndromes induced by drugs.
Topics: Antibodies, Antinuclear; Antibody Formation; Arthritis, Rheumatoid; Chlorpromazine; DNA, Single-Stranded; Drug-Related Side Effects and Adverse Reactions; False Positive Reactions; Female; Fluorescent Antibody Technique; Glucocorticoids; Humans; Hydralazine; Isoantigens; Isoniazid; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Neutrophils; Nucleoproteins; Penicillamine; Phenytoin; Procainamide; Remission, Spontaneous; Syphilis Serodiagnosis | 1974 |
Drug-induced lupus: clinical and serological studies.
Topics: Acetyltransferases; Adult; Antibodies, Antinuclear; Anticonvulsants; Arthritis; Chlorpromazine; Cross Reactions; Female; Genes, MHC Class II; HLA-DR Antigens; Humans; Hydralazine; Hypertension; Isoniazid; Joint Diseases; Lupus Erythematosus, Systemic; Male; Middle Aged; Pain; Pleural Effusion; Pleurisy; Procainamide; T-Lymphocytes | 1982 |
Drug-induced systemic lupus erythematosus.
Topics: Antibodies, Antinuclear; Anticonvulsants; Chlorpromazine; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Procainamide | 1980 |
43 other study(ies) available for chlorpromazine and procainamide
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.
Topics: Computational Biology; HeLa Cells; Humans; Models, Molecular; Organic Cation Transporter 1; Pyridinium Compounds; Quinolinium Compounds; Structure-Activity Relationship; Transfection | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Drug-induced disorders of lupus erythematosus type (author's transl)].
Topics: Animals; Antibody Formation; Anticonvulsants; Chlorpromazine; Drug-Related Side Effects and Adverse Reactions; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Penicillamine; Procainamide; Rats | 1977 |
[Drug-induced systemic lupus erythematosus (author's transl)].
Topics: Adolescent; Aged; Anti-Bacterial Agents; Antibody Formation; Autoantibodies; Child; Chlorpromazine; Female; Humans; Hydralazine; Immune Tolerance; Lupus Erythematosus, Systemic; Methyldopa; Practolol; Procainamide | 1977 |
Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin.
Topics: Autoantibodies; Chlorpromazine; Chromatin; DNA; Enzyme-Linked Immunosorbent Assay; Histones; Humans; Hydralazine; Immunoglobulin G; Immunoglobulin M; Lupus Vulgaris; Procainamide; Quinidine | 1991 |
Connective-tissue effects of drugs causing lupoid syndrome.
Topics: Animals; Carbon Radioisotopes; Chick Embryo; Chlorpromazine; Collagen; Depression, Chemical; Glucosamine; Hydralazine; Hydroxylation; Hydroxylysine; Hydroxyproline; Lupus Erythematosus, Systemic; Lysine; Mucoproteins; Procainamide; Proline; Tibia | 1974 |
Effect of some antihistaminic agents on the chronotropic response of adrenaline hydrochloride on isolated rat atria.
Topics: Animals; Chlorpheniramine; Chlorpromazine; Epinephrine; Heart; Heart Atria; Heart Rate; Histamine H1 Antagonists; Imidazoles; Lidocaine; Procainamide; Prochlorperazine; Rats | 1970 |
The physico-chemical incompatibilities of selected cardiovascular and psychotherapeutic agents with sodium ethacrynate.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Chlorpromazine; Drug Combinations; Drug Compounding; Drug Incompatibility; Drug Stability; Ethacrynic Acid; Hydralazine; Hydrogen-Ion Concentration; Procainamide; Prochlorperazine; Promazine; Reserpine; Spectrum Analysis; Time Factors; Tolazoline; Tranquilizing Agents; Triflupromazine; Ultraviolet Rays | 1972 |
[Biochemical knowledge in the anesthesiology. 8].
Topics: Amphetamine; Aniline Compounds; Chloramphenicol; Chlorpromazine; Electron Transport; Meperidine; Microsomes; Pentobarbital; Pharmaceutical Preparations; Procainamide; Quinolines; Thiopental | 1970 |
Further studies on F1-ATPase inhibition by local anesthetics.
Topics: Adenosine Triphosphatases; Anesthetics, Local; Animals; Cattle; Chlorpromazine; Dibucaine; Kinetics; Lidocaine; Mitochondria; Mitochondria, Heart; Oxidative Phosphorylation Coupling Factors; Procainamide; Procaine; Propranolol; Proton-Translocating ATPases; Submitochondrial Particles; Tetracaine | 1982 |
Effects of some membrane perturbers on alpha 1-adrenergic receptor binding.
Topics: Animals; Cattle; Cerebral Cortex; Chlorpromazine; Dibucaine; Dioxanes; Lidocaine; Membranes; Mepivacaine; Phenytoin; Procainamide; Procaine; Propranolol; Quinidine; Receptors, Adrenergic; Receptors, Adrenergic, alpha | 1981 |
The neurobiologically active benzamides and related compounds: some historical aspects.
Topics: Benzamides; Chlorpromazine; Haloperidol; History, 20th Century; Humans; Metoclopramide; Nervous System; Procainamide; Sulpiride | 1982 |
Inhibition of two monomeric butyrylcholinesterases from rabbit liver by chlorpromazine and other drugs.
Topics: Animals; Binding Sites; Chlorpromazine; Cholinesterase Inhibitors; Cholinesterases; Humans; Imipramine; Kinetics; Liver; Procainamide; Rabbits | 1981 |
Introduction to drug-related lupus.
Topics: Acetylation; Acetyltransferases; Animals; Anticonvulsants; Autoimmune Diseases; Child; Chlorpromazine; Female; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Phenothiazines; Procainamide; Sulfadiazine | 1981 |
Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils.
Topics: Animals; Biological Assay; Biotransformation; Cell Death; Chlorpromazine; Humans; Hydralazine; Hydrogen Peroxide; Isoniazid; Lupus Erythematosus, Systemic; Mice; Neutrophil Activation; Neutrophils; Peroxidase; Procainamide; Propylthiouracil; Quinidine; Tumor Cells, Cultured | 1994 |
[Controlled hypotension with RP 4560 and procaine amide; 40 cases].
Topics: Chlorpromazine; Hypotension; Hypotension, Controlled; Procainamide | 1955 |
A comparative anti-emetic study of o-chlor-procaine-amide and chlorpromazine in dogs.
Topics: Amides; Animals; Antiemetics; Chlorpromazine; Dogs; Procainamide; Procaine | 1960 |
[DRUGS FOR TREATING ARRHYTHMIA].
Topics: Arrhythmias, Cardiac; Chlorpromazine; Digitalis Glycosides; Humans; Pharmacology; Potassium; Procainamide; Quinacrine; Quinidine; Reserpine | 1963 |
[RE-ANESTHESIA].
Topics: Adjuvants, Anesthesia; Anesthesia; Anesthesia, General; Anesthesiology; Atropa belladonna; Atropine; Barbiturates; Chlorpromazine; Dihydroergotoxine; Ergot Alkaloids; Humans; Meperidine; Methadone; Morphine; Procainamide; Promazine; Promethazine; Reserpine; Scopolamine | 1964 |
[Prolonged paroxysmal tachycardia of the arterioventricular node during Wolff-Parkinson-White syndrome; failure of procaine amide; effectivity of intravenous chlorpromazine].
Topics: Cardiovascular Diseases; Chlorpromazine; Heart Block; Procainamide; Tachycardia; Tachycardia, Paroxysmal; Wolff-Parkinson-White Syndrome | 1954 |
Antibodies to non-bilayer phospholipid arrangements induce a murine autoimmune disease resembling human lupus.
Topics: Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Autoantibodies; Autoimmune Diseases; Chlorpromazine; Disease Models, Animal; Female; Liposomes; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Phospholipids; Procainamide; Specific Pathogen-Free Organisms | 2004 |
Molecular organization of the non-bilayer phospholipid arrangements that induce an autoimmune disease resembling human lupus in mice.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Cardiolipins; Cattle; Chlorpromazine; Kidney Glomerulus; Lupus Erythematosus, Systemic; Manganese; Mice; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylserines; Procainamide; Skin; Unilamellar Liposomes | 2012 |